Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
about
Cytotoxic and targeted therapy for hereditary cancersSonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinomaThe role of GLI1 for 5-Fu resistance in colorectal cancerThe anti-cancer effects of itraconazole in epithelial ovarian cancerBasal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma.Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases.Repurposing itraconazole for the treatment of cancer.Arsenic trioxide targets MTHFD1 and SUMO-dependent nuclear de novo thymidylate biosynthesis.Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.Strategies to target the Hedgehog signaling pathway for cancer therapy.Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.Roles of the Hedgehog Signaling Pathway in Epidermal and Hair Follicle Development, Homeostasis, and Cancer.Arsenic trioxide induces the apoptosis and decreases NF-κB expression in lymphoma cell linesRole of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
P2860
Q26739366-962CC597-2678-4BE4-B7C9-FBA1A8D3D8DEQ28078947-1401345C-95AF-491C-BF18-27AC0D896C69Q33560768-7FD5A882-C5F2-4840-8F1C-532D1EE30E8BQ38696316-54EBB908-6D98-4E29-B6FF-48943E642EACQ38748824-28BE72CA-B464-4081-BA08-A79EABCDE586Q38820516-93CBF326-1E40-4613-A259-CC7F117C4564Q41306560-DDE53AFD-5583-4579-9297-F4A9EBD1D480Q41613808-6CAC2B64-F12F-4A26-A0AD-7E58C6320BC3Q41710207-DF285893-58B0-48F7-9874-499BA08C2506Q42514766-7E03A007-679D-49BD-B853-468D8A4F42F6Q47218042-E46045CF-DFC4-4ACF-97A7-2A10773C6936Q48106107-5531AC94-E7FA-4F6A-A399-9678A8790715Q49251004-568C9553-937A-4C86-8D79-E519A4505FB6Q55081201-4C150E16-EEB5-4B1D-9F7E-86D9AC2DE87CQ58573158-8DFA31B7-30E4-4119-9210-A6DF951781FBQ58692807-4612FABB-3BA0-44F9-B276-C1DA3B52B20D
P2860
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effects of Combined Treatment ...... tastatic Basal Cell Carcinoma.
@ast
Effects of Combined Treatment ...... tastatic Basal Cell Carcinoma.
@en
type
label
Effects of Combined Treatment ...... tastatic Basal Cell Carcinoma.
@ast
Effects of Combined Treatment ...... tastatic Basal Cell Carcinoma.
@en
prefLabel
Effects of Combined Treatment ...... tastatic Basal Cell Carcinoma.
@ast
Effects of Combined Treatment ...... tastatic Basal Cell Carcinoma.
@en
P2093
P2860
P1433
P1476
Effects of Combined Treatment ...... etastatic Basal Cell Carcinoma
@en
P2093
A Dimitrios Colevas
Anne Lynn S Chang
Anthony Oro
Irene Bailey-Healy
Jean Y Tang
Katherine Ransohoff
Melika Rezaee
Mina S Ally
Philip A Beachy
P2860
P304
P356
10.1001/JAMADERMATOL.2015.5473
P407
P577
2016-04-01T00:00:00Z